Adenosine kinase expression in cortical dysplasia with balloon cells: Analysis of developmental lineage of cell types

Journal of Neuropathology and Experimental Neurology

Volumn 74, Issue 2, 2015, Pages 132-147

  Luan, Guoming ^a   Gao, Qing ^b   Zhai, Feng ^a   Zhou, Jian ^a   Liu, Changqing ^a   Chen, Yin ^b   Li, Tianfu ^b  

^a Brain Institute   (United States)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Adenosine kinase; Balloon cell; Development of brain; Focal cortical dysplasia

Indexed keywords

ADENOSINE KINASE; BETA TUBULIN; BIOLOGICAL MARKER; GLIAL FIBRILLARY ACIDIC PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 2; NESTIN; PROTEIN BCL 2; VIMENTIN; MICROTUBULE ASSOCIATED PROTEIN; TUBB3 PROTEIN, HUMAN; TUBULIN;

ARTICLE; ASTROCYTE; BALLOON CELL; CELL LINEAGE; CELL MATURATION; CELL POPULATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL DYSPLASIA; DISEASE ASSESSMENT; ENZYME ACTIVITY; EPILEPSY; FEMALE; GLIA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MULTIPOTENT STEM CELL; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING; ADOLESCENT; ADULT; BRAIN CORTEX; COMPLICATION; GENE EXPRESSION REGULATION; MALFORMATION OF CORTICAL DEVELOPMENT GROUP I; METABOLISM; PATHOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; YOUNG ADULT;

ADENOSINE KINASE; ADOLESCENT; ADULT; CEREBRAL CORTEX; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MALE; MALFORMATIONS OF CORTICAL DEVELOPMENT, GROUP I; MICROTUBULE-ASSOCIATED PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUBULIN; VIMENTIN; YOUNG ADULT;

EID: 84921902110     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0000000000000156     Document Type: Article

References (49)

1. Mischel PS, Nguyen LP, Vinters HV. Cerebral cortical dysplasia associated with pediatric epilepsy. Review of neuropathologic features and proposal for a grading system. J Neuropathol Exp Neurol 1995;54:137-53
2. Palmini A, Najm I, Avanzini G, et al. Terminology and classification of the cortical dysplasias. Neurology 2004;62:S2YS8.
3. Fauser S, Huppertz HJ, Bast T, et al. Clinical characteristics in focal cortical dysplasia: A retrospective evaluation in a series of 120 patients. Brain 2006; 129:1907-16
4. Yasin SA, Ali AM, Tata M, et al. mTOR-dependent abnormalities in autophagy characterize human malformations of cortical development: Evidence from focal cortical dysplasia and tuberous sclerosis. Acta Neuropathol 2013;126:207-18
5. Barkovich AJ, Guerrini R, Kuzniecky RI, et al. A developmental and genetic classification for malformations of cortical development: Update 2012. Brain 2012;135:1348-69
6. Schwartzkroin PA, Walsh CA. Cortical malformations and epilepsy. Ment Retard Dev Disabil Res Rev 2000;6:268-80
7. Yamanouchi H, Jay V, Otsubo H, et al. Early forms of microtubule-associated protein are strongly expressed in cortical dysplasia. Acta Neuropathol 1998; 95:466-70
8. Yamanouchi H, Zhang W, Jay V, et al. Enhanced expression of microtubule-associated protein 2 in large neurons of cortical dysplasia. Ann Neurol 1996;39:57-61
9. Ying Z, Gonzalez-Martinez J, Tilelli C, et al. Expression of neural stem cell surface marker CD133 in balloon cells of human focal cortical dysplasia. Epilepsia 2005;46:1716-23
10. Han CW, Min BW, Kim Y, et al. Immunohistochemical analysis of developmental neural antigen expression in the balloon cells of focal cortical dysplasia. J Clin Neurosci 2011;18:114-18
11. Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell 2012;149:274-93
12. Orlova KA, Tsai V, Baybis M, et al. Early progenitor cell marker expression distinguishes type II from type I focal cortical dysplasias. J Neuropathol Exp Neurol 2010;69:850-63
13. Baybis M, Yu J, Lee A, et al. mTOR cascade activation distinguishes tubers from focal cortical dysplasia. Ann Neurol 2004;56:478-87
14. Crino PB. mTOR: A pathogenic signaling pathway in developmental brain malformations. Trends Mol Med 2011;17:734-42
15. Fredholm BB, IJzerman AP, Jacobson KA, et al. International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptorsVAn update. Pharmacol Rev 2011;63:1-34
16. Wilz A, Pritchard EM, Li T, et al. Silk polymer-based adenosine release: Therapeutic potential for epilepsy. Biomaterials 2008;29:3609-16
17. Masino SA, Li T, Theofilas P, et al. A ketogenic diet suppresses seizures in mice through adenosine A(1) receptors. J Clin Invest 2011;121:2679-83
18. Li T, Steinbeck JA, Lusardi T, et al. Suppression of kindling epileptogenesis by adenosine releasing stem cellYderived brain implants. Brain 2007;130:1276-88
19. Li T, Ren G, Lusardi T, et al. Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice. J Clin Invest 2008;118:571-82
20. During MJ, Spencer DD. Adenosine: A potential mediator of seizure arrest and postictal refractoriness. Ann Neurol 1992;32:618-24
21. Gouder N, Scheurer L, Fritschy JM, et al. Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis. J Neurosci 2004;24: 692-701
22. Fedele DE, Gouder N, Guttinger M, et al. Astrogliosis in epilepsy leads to overexpression of adenosine kinase, resulting in seizure aggravation. Brain 2005;128:2383-95
23. Boison D. Adenosine kinase, epilepsy and stroke: Mechanisms and therapies. Trends Pharmacol Sci 2006;27:652-58
24. Aronica E, Zurolo E, Iyer A, et al. Upregulation of adenosine kinase in astrocytes in experimental and human temporal lobe epilepsy. Epilepsia 2011;52:1645-55
25. Boison D. The adenosine kinase hypothesis of epileptogenesis. Prog Neurobiol 2008;84:249-62
26. Boison D. Adenosine dysfunction in epilepsy. Glia 2012;60:1234-43
27. Li T, Lytle N, Lan JQ, et al. Local disruption of glial adenosine homeostasis in mice associates with focal electrographic seizures: A first step in epileptogenesis? Glia 2012;60:83-95
28. de Groot M, Iyer A, Zurolo E, et al. Overexpression of ADK in human astrocytic tumors and peritumoral tissue is related to tumor-associated epilepsy. Epilepsia 2012;53:58-66
29. Cui XA, Singh B, Park J, et al. Subcellular localization of adenosine kinase in mammalian cells: The long isoform of AdK is localized in the nucleus. Biochem Biophys Res Commun 2009;388:46-50
30. Luan G, Gao Q, Guan Y, et al. Upregulation of adenosine kinase in Rasmussen encephalitis. J Neuropathol Exp Neurol 2013;72:1000-8
31. Studer FE, Fedele DE, Marowsky A, et al. Shift of adenosine kinase expression from neurons to astrocytes during postnatal development suggests dual functionality of the enzyme. Neuroscience 2006;142:125-37
32. Shen HY, Li T, Boison D. A novel mouse model for sudden unexpected death in epilepsy (SUDEP): Role of impaired adenosine clearance. Epilepsia 2010;51:465-68
33. Boison D. Adenosine kinase: Exploitation for therapeutic gain. Pharmacol Rev 2013;65:906-43
34. Yasin SA, Latak K, Becherini F, et al. Balloon cells in human cortical dysplasia and tuberous sclerosis: Isolation of a pathological progenitor-like cell. Acta Neuropathol 2010;120:85-96
35. Fenech M. Chromosomal biomarkers of genomic instability relevant to cancer. Drug Discov Today 2002;7:1128-37
36. Glass M, Faull RL, Bullock JY, et al. Loss of A1 adenosine receptors in human temporal lobe epilepsy. Brain Res 1996;710:56-68
37. Boison D, Chen JF, Fredholm BB. Adenosine signaling and function in glial cells. Cell Death Differ 2010;17:1071-82
38. Theofilas P, Brar S, Stewart KA, et al. Adenosine kinase as a target for therapeutic antisense strategies in epilepsy. Epilepsia 2011;52:589-601
39. Aronica E, Sandau US, Iyer A, et al. Glial adenosine kinaseVA neuropathological marker of the epileptic brain. Neurochem Int 2013;63:688-95
40. Hadjivassiliou G, Martinian L, Squier W, et al. The application of cortical layer markers in the evaluation of cortical dysplasias in epilepsy. Acta Neuropathol 2010;120:517-28
41. Aronica E, Becker AJ, Spreafico R. Malformations of cortical development. Brain Pathol 2012;22:380-401
42. Lendahl U, Zimmerman LB, McKay RD. CNS stem cells express a new class of intermediate filament protein. Cell 1990;60:585-95
43. Messam CA, Hou J, Berman JW, et al. Analysis of the temporal expression of nestin in human fetal brain derived neuronal and glial progenitor cells. Brain Res Dev Brain Res 2002;134:87-92
44. Messam CA, Hou J, Major EO. Coexpression of nestin in neural and glial cells in the developing human CNS defined by a human-specific anti-nestin antibody. Exp Neurol 2000;161:585-96
45. Crino PB, Trojanowski JQ, Eberwine J. Internexin, MAP1B, and nestin in cortical dysplasia as markers of developmental maturity. Acta Neuropathol 1997;93:619-27
46. Palmer TD, Schwartz PH, Taupin P, et al. Cell culture. Progenitor cells from human brain after death. Nature 2001;411:42-43
47. Morshead CM, van der Kooy D. Postmitotic death is the fate of constitutively proliferating cells in the subependymal layer of the adult mouse brain. J Neurosci 1992;12:249-56
48. Ouyang YB, Giffard RG. Cellular neuroprotective mechanisms in cerebral ischemia: Bcl-2 family proteins and protection of mitochondrial function. Cell Calcium 2004;36:303-11
49. Raghupathi R. Cell death mechanisms following traumatic brain injury. Brain Pathol 2004;14:215-22